Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice.

Nijagal A, Wegorzewska M, Jarvis E, Le T, Tang Q, MacKenzie TC.

J Clin Invest. 2011 Feb;121(2):582-92. doi: 10.1172/JCI44907. Epub 2011 Jan 18.

4.

Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice.

Nijagal A, Derderian C, Le T, Jarvis E, Nguyen L, Tang Q, Mackenzie TC.

Blood. 2013 May 30;121(22):4595-602. doi: 10.1182/blood-2012-10-463174. Epub 2013 Apr 22.

5.

Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice.

Merianos DJ, Tiblad E, Santore MT, Todorow CA, Laje P, Endo M, Zoltick PW, Flake AW.

J Clin Invest. 2009 Sep;119(9):2590-600. doi: 10.1172/JCI38979. Epub 2009 Aug 3.

6.

In utero hematopoietic stem-cell transplantation--a match for mom.

Parolini O.

N Engl J Med. 2011 Mar 24;364(12):1174-5. doi: 10.1056/NEJMcibr1100692. No abstract available.

PMID:
21428775
7.

CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.

Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW.

Blood. 2006 Dec 15;108(13):4268-74. Epub 2006 Sep 5.

8.

The maternal immune response inhibits the success of in utero hematopoietic cell transplantation.

Nijagal A, Wegorzewska M, Le T, Tang Q, Mackenzie TC.

Chimerism. 2011 Apr;2(2):55-7. doi: 10.4161/chim.2.2.16287.

9.

A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution.

Chen BJ, Cui X, Sempowski GD, Gooding ME, Liu C, Haynes BF, Chao NJ.

Blood. 2002 Jan 1;99(1):364-71.

10.

New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.

Waller EK, Boyer M.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S20-4.

PMID:
10933181
11.

Hematopoietic cell transplantation for the induction of allo- and xenotolerance.

Sykes M.

Clin Transplant. 1996 Aug;10(4):357-63. Review.

PMID:
8884109
12.

Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.

Gaines BA, Colson YL, Kaufman CL, Ildstad S.

Exp Hematol. 1996 Jul;24(8):902-13.

PMID:
8690049
13.
14.
16.

The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.

Jiang Z, Adams GB, Hanash AM, Scadden DT, Levy RB.

Biol Blood Marrow Transplant. 2002;8(11):588-96.

PMID:
12463477
17.

Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection.

Shizuru JA, Weissman IL, Kernoff R, Masek M, Scheffold YC.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9555-60.

19.

In utero hematopoietic cell transplantation for the treatment of congenital anomalies.

Nijagal A, Flake AW, MacKenzie TC.

Clin Perinatol. 2012 Jun;39(2):301-10. doi: 10.1016/j.clp.2012.04.004. Epub 2012 May 8. Review.

PMID:
22682381
20.

Evidence for an immune barrier after in utero hematopoietic-cell transplantation.

Peranteau WH, Endo M, Adibe OO, Flake AW.

Blood. 2007 Feb 1;109(3):1331-3. Epub 2006 Oct 5.

Items per page

Supplemental Content

Write to the Help Desk